Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline

被引:58
作者
Chan, Christine L. [1 ,2 ]
Vigers, Timothy [1 ,2 ]
Pyle, Laura [1 ,2 ,3 ]
Zeitler, Philip S. [1 ,2 ]
Sagel, Scott D. [2 ,4 ]
Nadeau, Kristen J. [1 ,2 ]
机构
[1] Childrens Hosp Colorado, Div Pediat Endocrinol, Dept Pediat, Aurora, CO 80045 USA
[2] Univ Colorado, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO 80045 USA
[4] Childrens Hosp Colorado, Div Pediat Pulmonol, Dept Pediat, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
Cystic fibrosis related diabetes; Continuous glucose monitoring; Pediatrics; GLYCEMIC VARIABILITY; CHILDREN; TOLERANCE; HYPOGLYCEMIA; INTOLERANCE; ADOLESCENTS; INSIGHTS; ADULTS;
D O I
10.1016/j.jcf.2018.03.008
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: To characterize glucose patterns with continuous glucose monitoring (CGM) in cystic fibrosis (CF) and assess relationships between CGM and clinical outcomes. Methods: 110 CF youth and healthy controls (BC), 10-18 years, wore CGM up to 7 days. Correlations between CGM and lung function and BMI z-score change over the prior year were determined. Results: Multiple CGM measures were higher in CF Normal Glycemic (CFNG) youth versus HC (peak glucose, excursions >140 mg/dl/day, % time > 140 mg/dl, standard deviation (SD) and mean amplitude of glycemic excursions (MAGE)). Hypoglycemia was no different among groups. In CF, decline in FEV 1% and FVC% correlated with maximum CGM glucose, excursions >200 mg/dl/day, SD, and MAGE. Conclusions: CFNG youth have higher glucoses and glucose variability than HC on CGM. Higher and more variable glucoses correlate with lung function decline. Whether earlier treatment of CGM abnormalities improves lung function in CF requires further study. (C) 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:783 / 790
页数:8
相关论文
共 46 条
[1]  
Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc19-S002, 10.2337/dc18-S002]
[3]   Hypoglycaemia in cystic fibrosis in the absence of diabetes: A systematic review [J].
Armaghanian, N. ;
Brand-Miller, J. C. ;
Markovic, T. P. ;
Steinbeck, K. S. .
JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (03) :274-284
[4]   Spontaneous hypoglycemia in patients with cystic fibrosis [J].
Battezzati, A. ;
Battezzati, P. M. ;
Costantini, D. ;
Seia, M. ;
Zazzeron, L. ;
Russo, M. C. ;
Dacco, V. ;
Bertoli, S. ;
Crosignani, A. ;
Colombo, C. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (03) :369-376
[5]   Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis [J].
Brennan, Amanda L. ;
Gyi, Khin M. ;
Wood, David M. ;
Johnson, Julie ;
Holliman, Rick ;
Baines, Deborah L. ;
Philips, Barbara J. ;
Geddes, Duncan M. ;
Hodson, Margaret E. ;
Baker, Emma H. .
JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (02) :101-109
[6]   Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis [J].
Brodsky, Jill ;
Dougherty, Shayne ;
Makani, Ramkrishna ;
Rubenstein, Ronald C. ;
Kelly, Andrea .
DIABETES CARE, 2011, 34 (02) :292-295
[7]   Glycemic variability:: A hemoglobin A1c-independent risk factor for diabetic complications [J].
Brownlee, M ;
Hirsch, IB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1707-1708
[8]  
CUCINOTTA D, 1994, J PEDIATR ENDOCRINOL, V7, P13
[9]  
Cystic Fibrosis Foundation Patient Registry, 2015, ANN DAT REP
[10]   1ST-PHASE INSULIN RELEASE IN ADULT CYSTIC-FIBROSIS PATIENTS - CORRELATION WITH CLINICAL AND BIOLOGICAL PARAMETERS [J].
DESCHEPPER, J ;
HACHIMIIDRISSI, S ;
SMITZ, J ;
DAB, I ;
LOEB, H .
HORMONE RESEARCH, 1992, 38 (5-6) :260-263